ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag peer review immunology ecology

Capsule Reviews
Bob Grant | May 1, 2014 | 3 min read
Madness and Memory, Promoting the Planck Club, The Carnivore Way, and The Tale of the Dueling Neurosurgeons
Week in Review: September 22–26
Tracy Vence | Sep 26, 2014 | 2 min read
Assessing PubPeer’s legal threat; how lengthy ICU stays impact the gut microbiome; gene links exercise to reduced depression risk; epigenetics of innate immunity; Ebola updates
Week in Review: January 30–February 3
Joshua A. Krisch | Feb 2, 2017 | 3 min read
March for science debate; an RNA vaccine for Zika; responses to Trump’s immigration order; native habitat restoration; views from local March for Science organizers; artificial cells and the Turing test
Week in Review: May 26–30
Tracy Vence | May 30, 2014 | 4 min read
Human proteome cataloged; island-separated crickets evolved silence; molecule shows promise for combatting coronaviruses; study replication etiquette; another call for STAP retraction
How Some Vaccines Protect Against More than Their Targets
Shawna Williams | Nov 1, 2020 | 10+ min read
As researchers test existing vaccines for nonspecific protection against COVID-19, immunologists are working to understand how some inoculations protect against pathogens they weren’t designed to fend off.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Consumer Fear Cancels European GM Research
Alexander Hellemans | May 4, 2003 | 10 min read
Erica P. Johnson A new Eurobarometer, surveying attitudes about science among citizens of the ten countries that recently entered the European Union, suggests that genetically modified (GM) organisms are only slightly more tolerable to these "new Europeans" than to their peers on the rest of the continent. Seventy-nine percent of the 12,247 people surveyed in 13 countries by the Gallup Organization in Hungary say GM foods should be introduced only if proven safe, compared with 86% of the 16,02
Notebook
The Scientist Staff | Aug 20, 1995 | 7 min read
Panels Under The Axe Human-Embryo Research Opposition Telemedicine Delivers A Diagnosis Symposia Mark Pasteur's Passing Microbiologists Stake Home Page Dr. Seuss, Capitalist Tool Funding Novice Biomedical Faculty Math Medalists The AIDS Research Evaluation Working Group and six Area Review Panels currently charged with evaluating all National Institutes of Health-sponsored AIDS research (B. Goodman, The Scientist, July 10, 1995, page 1) find themselves facing a challenge they may not be abl
Observers Praise AIDS Report But Foresee Problems In Implementation
Steven Benowitz | May 12, 1996 | 10 min read
Problems In Implementation LOUD AND CLEAR: Attorney Lynda Dee stresses the need for communication among the institutes. When a federally appointed panel announced in March the results of its 15-month-long review of the United States government's AIDS research program, AIDS activists as well as scientists cheered. The National Institutes of Health's AIDS Research Program Evaluation Working Group's recommendations largely called for scrapping what the group saw as outdated and ineffective polic
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.

Run a Search

ADVERTISEMENT